OGN vs SNCR · P/E 3.4, rev $3.02B vs rev $173.6M
Organon & Co (OGN) versus Synchronoss Technologies Inc (SNCR) — a side-by-side from cached financials, not a winner call.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Synchronoss Technologies Inc (SNCR) is a software - infrastructure company listed on NASDAQ.
Latest reported OGN revenue for 2026-06-30 was $3.02B. Net income was $254.0M. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Latest reported SNCR revenue for 2024-12-31 was $173.6M. Net income was $6.2M. Revenue was up 319.3% from 2023-12-31 to 2024-12-31. SNCR currently screens at market cap $103.6M.
OGN currently screens at market cap $2.52B and trailing P/E 3.4. SNCR currently screens at market cap $103.6M.
Not investment advice. Open the OGN and SNCR stock pages for the full models.
Not investment advice.